Oligodendroglioma (WHO grade I) in a young epilepsy patient: A specific entity lying within the spectrum of dysembryoplastic neuroepithelial tumor?

Neuropathology

Volumn 33, Issue 6, 2013, Pages 645-651

  Takahashi, Hitoshi ^a   Kakita, Akiyoshi ^a   Tomikawa, Masaru ^b   Okamoto, Kouichirou ^a   Kameyama, Shigeki ^b  

^a NIIGATA UNIVERSITY   (Japan)

^b NISHI NIIGATA CHUO NATIONAL HOSPITAL   (Japan)

Author keywords

Cortical dysplasia; Dysembryoplastic neuroepithelial tumor; Epilepsy; Mucinous matrix; Oligodendroglioma

Indexed keywords

ANTICONVULSIVE AGENT; CELL NUCLEUS ANTIGEN; GADOLINIUM; GLIAL FIBRILLARY ACIDIC PROTEIN; KI 67 ANTIGEN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; SYNAPTOPHYSIN; THALLIUM CHLORIDE TL 201; VIMENTIN;

ADOLESCENT; ANTICONVULSANT THERAPY; ARTICLE; BRAIN CAPILLARY; BRAIN CORTEX; BRAIN EDEMA; CASE REPORT; CELL NUCLEUS; CELL ULTRASTRUCTURE; CHROMOSOME 19Q; CHROMOSOME 1P; CONTRAST ENHANCEMENT; CORTICAL DYSPLASIA; ELECTRON MICROSCOPY; EPILEPTIC FOCUS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOCAL EPILEPSY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACTABLE EPILEPSY; LABELING INDEX; MIDDLE FRONTAL GYRUS; NEUROEPITHELIOMA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; OLIGODENDROGLIOMA; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR CELL; TUMOR CLASSIFICATION; WHITE MATTER;

CORTICAL DYSPLASIA; DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR; EPILEPSY; MUCINOUS MATRIX; OLIGODENDROGLIOMA;

ADOLESCENT; BRAIN NEOPLASMS; EPILEPSY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS, NEUROEPITHELIAL; NEUROSURGICAL PROCEDURES; OLIGODENDROGLIOMA;

EID: 84897084769     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/neup.12026     Document Type: Article

References (27)

1. Luyken C, Blümcke I, Fimmers R etal. The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia 2003; 44: 822-830.
2. Thom M, Blümcke I, Aronica E. Long-term epilepsy-associated tumors. Brain Pathol 2012; 22: 359-379.
3. Blümcke I. Epilepsy-associated brain tumors. Handb Clin Neurol 2012; 108: 559-568.
4. Reifenberger G, Kros JM, Louis DN, Colllins VP. Oligodendroglioma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumours of the Central Nervous System, 4th edn. Lyon: IARCP, 2007; 54-59.
5. Daumas-Duport C, Pietsch T, Hawkins C, Shankar SK. Dysembryoplastic neuroepithelial tumor. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumours of the Central Nervous System, 4th edn. Lyon: IARCP, 2007; 99-102.
6. Daumas-Duport C, Varlet P, Bacha S, Beuvon F, Cervera-Pierot P, Chodkiewicz JP. Dysembryoplastic neuroepithelial tumors: nonspecific histological forms - a study of 40 cases. J Neurooncol 1999; 41: 267-280.
7. Jeon YK, Park K, Park CK, Paek SH, Jung HW, Park S-H. Chromosome 1p and 19q status and p53 and p16 expression patterns as prognostic indicators of oligodendroglial tumors: a clinicopathological study using fluorescence in situ hybridization. Neuropathology 2007; 27: 10-20.
8. Asano K, Kudo K, Mori F, Ohkuma H, Wakabayashi K. A case of clear cell ependymoma presenting with high erythropoietin concentration and 1p/19q deletion. Brain Tumor Pathol 2011; 28: 317-327.
9. Fallon KB, Palmer CA, Roth KA etal. Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas. J Neuropathol Exp Neurol 2004; 63: 314-322.
10. Blümcke I, Thom M, Aronica E etal. The clinicopathological spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 2011; 52: 158-174.
11. Peters A, Palay SL, Webster HF. The Fine Structure of the Nervous System, 3rd edn. New York: Oxford University Press, 1991; 295-304.
12. Min K-W, Scheithauer BW. Oligodendroglioma: the ultrastructural spectrum. Ultrastruct Pathol 1994; 18: 47-60.
13. Herpers MJ, Budka H. Glial fibrillary acidic protein (GFAP) in oligodendroglial tumors: gliofibrillary oligodendroglioma and transitional oligoastrocytoma as subtypes of oligodendroglioma. Acta Neuropathol 1984; 64: 265-272.
14. Nakagawa Y, Perentes E, Rubinstein LJ. Immunohistochemical characterization of oligodendrogliomas: an analysis of multiple markers. Acta Neuropathol 1986; 72: 15-22.
15. Kros JM, de Jong AA, van der Kwast TH. Ultrastructural characterization of transitional cells in oligodendrogliomas. J Neuropathol Exp Neurol 1992; 51: 186-193.
16. Sarkar C, Roy S, Tandon PN. Oligodendroglial tumors. An immunohistochemical and electron microscopic study. Cancer 1988; 61: 1862-1866.
17. Ligon KL, Alberta JA, Kho AT etal. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas. J Neuropathol Exp Neurol 2004; 64: 499-509.
18. Dehghani F, Schachenmayr W, Laun A, Korf HW. Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: a study of 89 cases. Acta Neuropathol 1998; 95: 493-504.
19. Blümcke I, Becker AJ, Normann S etal. Distinct expression pattern of microtuble-associated protein-2 in human oligodendrogliomas and glial precursor cells. J Neuropathol Exp Neurol 2001; 60: 984-993.
20. Katsetos CD, Del Valle L, Geddes JF etal. Localization of the neuronal class III beta-tubulin in oligodendrogliomas: comparison with Ki-67 proliferative index and 1p/19q status. J Neuropathol Exp Neurol 2002; 61: 307-320.
21. McLendon RE, Enterline DS, Tien RD, Thorstad WL, Bruner JM. Tumors of central neuroepithelial origin (Oligodendroglioma). In: Bigner DD, McLendon RE, Bruner JM, eds. Russell and Rubinstein's Pathology of Tumors of the Nervous System, 6th edn. London: Arnold, 1998; 370-308.
22. McLendon RE, Kros JM, Bruner J, Gray L. Oligodendroglioma. In: McLendon RE, Rosenblum MK, Bigner DD, eds. Russell and Rubinstein's Pathology of Tumors of the Nervous System, 7th edn. London: Hodder Arnold, 2006; 167-185.
23. Daumas-Duport C, Scheithauer BW, Chodkiewicz JP, Laws ER Jr, Vedrenne C. Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery 1988; 23: 545-556.
24. Daumas-Duport C. Dysembryoplastic neuroepithelial tumours. Brain Pathol 1993; 3: 283-295.
25. Preusser M, Budka H, Rössler K, Hainfellner JA. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms. Histopathology 2007; 50: 365-370.
26. Matsumura N, Yokoo H, Mao Y, Yin W, Nakazato Y. Olig2-positive cells in glioneuronal tumors show both glial and neuronal characters: the implication of a common progenitor cell? Neuropathology 2013; 33: 246-255.
27. Komori T. Morphological spectrum of brain tumors in patients with intractable epilepsy. Neuropathology 2012; 32: 321.